INmune Bio - Stock Price History | INMB

Historical daily share price chart and data for INmune Bio since 2021 adjusted for splits. The latest closing stock price for INmune Bio as of September 27, 2021 is 20.54.
  • The all-time high INmune Bio stock closing price was 27.85 on September 07, 2021.
  • The INmune Bio 52-week high stock price is 30.37, which is 47.9% above the current share price.
  • The INmune Bio 52-week low stock price is 7.28, which is 64.6% below the current share price.
  • The average INmune Bio stock price for the last 52 weeks is 14.95.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
INmune Bio Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 7.3163 6.1530 17.2200 2.2100 17.2200 196.90%
2019 7.4864 7.9900 11.0000 3.5600 5.8000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.366B $0.000B
INmune Bio Inc. is a clinical-stage biotechnology company. It engages in developing therapies targeting the innate immune system in cancer. The company's product platform consists of INKmune and INB03. INKmune is a natural killer cell therapeutic which primes the patient's NK cells to attack developing disease. INB03 inhibits myeloid derived suppressor cells which often cause resistance to immunotherapy, such as anti-PD1 checkpoint inhibitors. INmune Bio Inc. is based in La Jolla, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29